These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24007744)

  • 41. [The clinical use of the IWG diagnostic criteria for Alzheimer's disease: A retrospective study in a memory clinic].
    Inthasot V; Segers K; Vanderaspoilden V; Guisset F; Dachy B
    Rev Med Brux; 2016; 37(6):460-468. PubMed ID: 28525173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alzheimer's disease diagnostic criteria: practical applications.
    Cummings J
    Alzheimers Res Ther; 2012; 4(5):35. PubMed ID: 22947665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biomarker of dementia: clinical and preclinical diagnosis].
    Shoji M
    Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are specific symptoms of depression predictive of Alzheimer's dementia?
    Mossaheb N; Zehetmayer S; Jungwirth S; Weissgram S; Rainer M; Tragl KH; Fischer P
    J Clin Psychiatry; 2012 Jul; 73(7):1009-15. PubMed ID: 22687442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A proposal for diagnostic and clinical assessment criteria for Alzheimer's disease].
    Shoji M; Kuwano R; Asada T; Imagawa M; Higuchi S; Urakami K; Arai H; Ihara Y; ;
    Rinsho Shinkeigaku; 2005 Feb; 45(2):128-37. PubMed ID: 15782613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Validation of the Quality of Life in Alzheimer's Disease (QOL-AD) scale in Mexican patients with Alzheimer, vascular and mixed-type dementia].
    Rosas-Carrasco O; Torres-Arreola Ldel P; Guerra-Silla Mde G; Torres-Castro S; Gutierrez-Robledo LM
    Rev Neurol; 2010 Jul; 51(2):72-80. PubMed ID: 20602312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease: the problem of incorrect clinical diagnosis.
    McDaniel LD; Lukovits T; McDaniel KD
    J Geriatr Psychiatry Neurol; 1993; 6(4):230-4. PubMed ID: 8251052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of DSM-5 and IWG-2 criteria for the diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Baker KG
    Diagnosis (Berl); 2016 Mar; 3(1):9-12. PubMed ID: 29540044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.
    Lim A; Tsuang D; Kukull W; Nochlin D; Leverenz J; McCormick W; Bowen J; Teri L; Thompson J; Peskind ER; Raskind M; Larson EB
    J Am Geriatr Soc; 1999 May; 47(5):564-9. PubMed ID: 10323650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving Alzheimer's disease phase II clinical trials.
    Greenberg BD; Carrillo MC; Ryan JM; Gold M; Gallagher K; Grundman M; Berman RM; Ashwood T; Siemers ER
    Alzheimers Dement; 2013 Jan; 9(1):39-49. PubMed ID: 23164548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Research and standardization in Alzheimer's trials: reaching international consensus.
    Carrillo MC; Rowe CC; Szoeke C; Masters CL; Ames D; O'Meara T; Macaulay SL; Milner A; Ellis KA; Maruff P; Rainey-Smith SR; Martins RN; Bain LJ; Head RJ;
    Alzheimers Dement; 2013 Mar; 9(2):160-8. PubMed ID: 23266004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renovating Alzheimer's: "constructive" reflections on the new clinical and research diagnostic guidelines.
    George DR; Qualls SH; Camp CJ; Whitehouse PJ
    Gerontologist; 2013 Jun; 53(3):378-87. PubMed ID: 22936533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NIA funding for Alzheimer's research.
    Barr RA
    Lancet Neurol; 2011 Aug; 10(8):683. PubMed ID: 21777823
    [No Abstract]   [Full Text] [Related]  

  • 57. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
    Carrillo MC; Sanders CA; Katz RG
    Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systems-based model of Alzheimer's disease.
    Tang Y; Lutz MW; Xing Y
    Alzheimers Dement; 2019 Jan; 15(1):168-171. PubMed ID: 30102884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Silverberg N; Elliott C; Ryan L; Masliah E; Hodes R
    Alzheimers Dement; 2018 Apr; 14(4):576-578. PubMed ID: 29653608
    [No Abstract]   [Full Text] [Related]  

  • 60. Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease.
    James BD; Bennett DA
    Annu Rev Public Health; 2019 Apr; 40():65-84. PubMed ID: 30642228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.